Guy A. Caldwell

14.8k total citations · 2 hit papers
117 papers, 8.7k citations indexed

About

Guy A. Caldwell is a scholar working on Aging, Molecular Biology and Neurology. According to data from OpenAlex, Guy A. Caldwell has authored 117 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Aging, 51 papers in Molecular Biology and 46 papers in Neurology. Recurrent topics in Guy A. Caldwell's work include Genetics, Aging, and Longevity in Model Organisms (52 papers), Parkinson's Disease Mechanisms and Treatments (37 papers) and Alzheimer's disease research and treatments (15 papers). Guy A. Caldwell is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (52 papers), Parkinson's Disease Mechanisms and Treatments (37 papers) and Alzheimer's disease research and treatments (15 papers). Guy A. Caldwell collaborates with scholars based in United States, Germany and Spain. Guy A. Caldwell's co-authors include Kim A. Caldwell, Shusei Hamamichi, Adam L. Knight, Susan Lindquist, Songsong Cao, Jean‐Christophe Rochet, Katherine E. Strathearn, Joseph R. Mazzulli, Aaron D. Gitler and Dimitri Krainc and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Guy A. Caldwell

116 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models

2006 1.1k citations Antony A. Cooper, Aaron D. Gitler et al. Science profile →
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

2011 1.0k citations Adam L. Knight, Guy A. Caldwell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guy A. Caldwell United States	47	3.7k	3.5k	2.5k	2.0k	2.0k	117	8.7k
Kim A. Caldwell United States	46	3.9k 1.1×	2.8k 0.8×	1.8k 0.7×	1.7k 0.8×	1.8k 0.9×	111	8.0k
Jean‐Christophe Rochet United States	37	4.0k 1.1×	5.4k 1.5×	4.0k 1.6×	1.6k 0.8×	2.5k 1.3×	108	10.3k
Mel Β. Feany United States	54	5.4k 1.5×	5.2k 1.5×	4.8k 1.9×	2.0k 1.0×	4.8k 2.4×	106	13.4k
Marta Martínez‐Vicente Spain	32	3.1k 0.8×	2.1k 0.6×	2.7k 1.1×	1.7k 0.8×	1.2k 0.6×	47	7.6k
Alexander J. Whitworth United Kingdom	36	3.9k 1.1×	3.4k 1.0×	1.6k 0.6×	903 0.4×	1.7k 0.9×	70	7.3k
Céline Perier Spain	33	2.6k 0.7×	3.5k 1.0×	1.8k 0.7×	531 0.3×	2.2k 1.1×	41	6.7k
Darren J. Moore United States	49	4.5k 1.2×	6.8k 1.9×	2.6k 1.0×	1.7k 0.8×	2.8k 1.4×	86	10.2k
Lichuan Yang United States	51	6.3k 1.7×	3.5k 1.0×	2.1k 0.8×	720 0.4×	4.0k 2.1×	79	10.7k
Wanli W. Smith United States	30	2.4k 0.7×	2.6k 0.7×	1.2k 0.5×	809 0.4×	1.3k 0.7×	70	5.1k
Han Seok Ko United States	33	4.0k 1.1×	4.2k 1.2×	2.0k 0.8×	1.0k 0.5×	2.2k 1.1×	58	8.5k

Countries citing papers authored by Guy A. Caldwell

Since Specialization

Citations

This map shows the geographic impact of Guy A. Caldwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy A. Caldwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy A. Caldwell more than expected).

Fields of papers citing papers by Guy A. Caldwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy A. Caldwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy A. Caldwell. The network helps show where Guy A. Caldwell may publish in the future.

Co-authorship network of co-authors of Guy A. Caldwell

This figure shows the co-authorship network connecting the top 25 collaborators of Guy A. Caldwell. A scholar is included among the top collaborators of Guy A. Caldwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy A. Caldwell. Guy A. Caldwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Hana, et al.. (2023). Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson’s disease models. Proceedings of the National Academy of Sciences. 120(7). e2210712120–e2210712120. 8 indexed citations

Caldwell, Kim A., et al.. (2023). Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a Caenorhabditis elegans α-synuclein model of Parkinson’s disease. iScience. 26(6). 106859–106859. 2 indexed citations

Caldwell, Guy A., et al.. (2023). Xanthine Dehydrogenase Is a Modulator of Dopaminergic Neurodegeneration in Response to Bacterial Metabolite Exposure in C. elegans. Cells. 12(8). 1170–1170. 8 indexed citations

Hamamichi, Shusei, et al.. (2022). Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans. PLoS Genetics. 18(8). e1010115–e1010115. 10 indexed citations

Fanning, Saranna, Jooyoung Jeong, Joon Yoon, et al.. (2022). Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy. npj Parkinson s Disease. 8(1). 74–74. 13 indexed citations

March, Zachary M., Hanna Kim, Xiaohui Yan, et al.. (2020). Therapeutic genetic variation revealed in diverse Hsp104 homologs. eLife. 9. 23 indexed citations

Tardiff, Daniel F., Nathan T. Jui, Vikram Khurana, et al.. (2013). Yeast Reveal a “Druggable” Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons. Science. 342(6161). 979–983. 200 indexed citations

Jui, Nathan T., Stephen L. Buchwald, Susan Lindquist, et al.. (2013). Yeast Reveal a ‘Druggable’ Rsp5/Nedd4 Network That Ameliorates α-Synuclein Toxicity in Neurons. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations

Shephard, Freya, Christopher Gaffney, Nathaniel J. Szewczyk, et al.. (2013). Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans Models of Human Neurodegenerative Diseases. Antioxidants and Redox Signaling. 20(2). 217–235. 48 indexed citations

10.

Harrington, Adam J., et al.. (2012). Functional Analysis of VPS41-Mediated Neuroprotection inCaenorhabditis elegansand Mammalian Models of Parkinson's Disease. Journal of Neuroscience. 32(6). 2142–2153. 65 indexed citations

11.

Liu, Zhaohui, Shusei Hamamichi, Byoung Dae Lee, et al.. (2011). Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models. Human Molecular Genetics. 20(20). 3933–3942. 108 indexed citations

12.

Tardiff, Daniel F., et al.. (2011). Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms. Journal of Biological Chemistry. 287(6). 4107–4120. 61 indexed citations

13.

Nery, Flávia C., Jonathan E. Farley, Pan Chen, et al.. (2011). TorsinA participates in endoplasmic reticulum-associated degradation. Nature Communications. 2(1). 393–393. 87 indexed citations

14.

Harrington, Adam J., Adam L. Knight, Guy A. Caldwell, & Kim A. Caldwell. (2011). Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson’s disease. Methods. 53(3). 220–225. 28 indexed citations

15.

Churchill, Perry F., et al.. (2010). The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro. Cell Stress and Chaperones. 15(5). 605–617. 47 indexed citations

16.

Harrington, Adam J., Shusei Hamamichi, Guy A. Caldwell, & Kim A. Caldwell. (2010). C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Developmental Dynamics. 239(5). 1282–1295. 109 indexed citations

17.

Caldwell, Kim A., Tyler W. Hodges, Jue Chen, et al.. (2009). Investigating Bacterial Sources of Toxicity as an Environmental Contributor to Dopaminergic Neurodegeneration. PLoS ONE. 4(10). e7227–e7227. 44 indexed citations

18.

Cooper, Antony A., Aaron D. Gitler, Anil G. Cashikar, et al.. (2006). α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models. Science. 313(5785). 324–328. 1064 indexed citations breakdown →

19.

Zhang, Shifang, et al.. (2004). MEC-2 Is Recruited to the Putative Mechanosensory Complex in C. elegans Touch Receptor Neurons through Its Stomatin-like Domain. Current Biology. 14(21). 1888–1896. 87 indexed citations

20.

Marcus, Stevan, et al.. (1990). Total in vitro maturation of the Saccharomyces cerevisiaea-factor lipopeptide mating pheromone. Biochemical and Biophysical Research Communications. 172(3). 1310–1316. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact